Detalles de la búsqueda
1.
Second-line tislelizumab versus chemotherapy in Japanese patients with advanced or metastatic esophageal squamous cell carcinoma: subgroup analysis from RATIONALE-302.
Esophagus
; 21(2): 102-110, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38240916
2.
Psychometric validation of the EORTC QLQ-HCC18 in patients with previously treated unresectable hepatocellular carcinoma.
Qual Life Res
; 31(3): 937-950, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34518988
3.
An observational, multicentre study of cabazitaxel in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (CAPRISTANA).
BJU Int
; 123(3): 456-464, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30098093
4.
Tislelizumab in advanced/metastatic esophageal squamous cell carcinoma: health-related quality of life in Asian patients.
Curr Med Res Opin
; 40(1): 69-75, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37846080
5.
Effects of tislelizumab on health-related quality of life in patients with recurrent or metastatic nasopharyngeal cancer.
Head Neck
; 2024 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38671587
6.
The effects of tislelizumab treatment on the health-related quality of life of patients with advanced non-small cell lung cancer.
Cancer Med
; 12(16): 17403-17412, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37587845
7.
Health-related quality of life outcomes associated with zanubrutinib versus ibrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma: results from the ALPINE Trial.
Curr Med Res Opin
; : 1-7, 2023 Sep 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37752892
8.
Health-related quality-of-life in treatment-naive CLL/SLL patients treated with zanubrutinib versus bendamustine plus rituximab.
Curr Med Res Opin
; : 1-7, 2023 Sep 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37752878
9.
Small cell lung cancer patients treated with immune checkpoint inhibitor: a systematic literature review of treatment efficacy, safety and quality of life.
Curr Med Res Opin
; 38(8): 1361-1368, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35575164
10.
Examining the Impact of Tislelizumab Added to Chemotherapy on Health-Related Quality-of-Life Outcomes in Previously Untreated Patients With Nonsquamous Non-Small Cell Lung Cancer.
Cancer J
; 28(2): 96-104, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35333492
11.
Real-World longitudinal practice patterns in the use of PD-1 and PD-L1 inhibitors as First-Line therapy in patients with Non-Small cell lung cancer in the United States.
Cancer Med
; 11(22): 4265-4272, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35499294
12.
Use of PD-1 and PD-L1 inhibitors after first-line therapy in esophageal cancer patients in the US.
Curr Med Res Opin
; 37(8): 1403-1407, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33989092
13.
Healthcare utilization and costs associated with tyrosine kinase inhibitor switching in patients with chronic myeloid leukemia.
Leuk Lymphoma
; 57(4): 935-41, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26480922
14.
Budgetary impact of treating acute promyelocytic leukemia patients with first-line arsenic trioxide and retinoic acid from an Italian payer perspective.
PLoS One
; 10(8): e0134587, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26267454
15.
Effectiveness of homoharringtonine (omacetaxine mepesuccinate) for treatment of acute myeloid leukemia: a meta-analysis of Chinese studies.
Clin Lymphoma Myeloma Leuk
; 15(1): 13-21, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25458084
16.
Cost-Effectiveness Analysis of Treating Acute Promyelocytic Leukemia Patients With Arsenic Trioxide and Retinoic Acid in the United States.
Clin Lymphoma Myeloma Leuk
; 15(12): 771-7, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26361645
17.
G-CSF utilization rate and prescribing patterns in United States: associations between physician and patient factors and GCSF use.
Cancer Med
; 3(6): 1477-84, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25410813
18.
Pharmacoeconomics of granulocyte colony-stimulating factor: a critical review.
Adv Ther
; 31(7): 683-95, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24989316
Resultados
1 -
18
de 18
1
Próxima >
>>